![](/img/cover-not-exists.png)
BMS-986263 (novel targeted lipid nanoparticle delivering HSP47 siRNA) safety and target engagement in patients with advanced hepatic fibrosis: week 36 results from a phase 2 randomized, double-blind, placebo-controlled trial
Lawitz, Eric, Shevell, Diane, Revankar, Ratna, Gao, Sheng, Wadhawan, Samir, Chen, Warner, Tirucherai, Giridhar, Du, Shuyan, Alkhouri, Naim, Coste, Angie, Poordad, Fred, Charles, EdgarVolume:
73
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(20)30778-9
Date:
August, 2020
File:
PDF, 251 KB
2020